PDCD1 and cancer: Altogether, these results demonstrate that Exo-PD-1 from T cells not only binds PD-L1 on the cell surface but also induces CME of PD-L1, thereby reducing the amount of surface PD-L1 available during subsequent cancer-to-T cell direct interaction.